ANAVOMICS METHODOLOGIES UNDERSTANDING THE COMPLEXITY OF BIOLOGICAL PROCESS

| April 5, 2017

article image
Multidimensional scaling is use to reduce the multidimensional network into a 2D map, generating a specific projection “fingerprint”. A repertory of cell-type specific 2D fingerprints based on previous experiments stored in GEO database has been generated. The cell-type fingerprints obtained can be envisaged as the average population. Thus, in addition to objectively quantifying the overall differences between samples, this revolutionary approach can measure the relative distance between any microarray sample and the cell type average.

Spotlight

Donald Danforth Plant Science Center

The Donald Danforth Plant Science Center is a not-for-profit research institute with a mission to improve the human condition through plant science. Scientists at the Danforth Center are engaged in research, which will contribute to feeding the hungry, improving human health, preserving and renewing the environment, and enhancing the St. Louis region and the State of Missouri as world centers for plant science.

OTHER ARTICLES

Ruminating on Bioprocessing 4.0

Article | February 18, 2020

The Bioprocessing 4.0 concept seeks to apply automation and technology to the digital transformation of biologics manufacturing. As the paradigm moves forward, it faces barriers to its adoption, according to Eric Langer, president of BioPlan Associates. “Perhaps the greatest challenges involve unsecured links and adapting the applications to areas where automation is critically needed today,” says Langer. “Unresolved security issues could seriously affect a company’s data in a regulated environment, so they will need to have iron-clad anti-hacking protection in place. Unfortunately, cyber security is not yet a top focus for the industry.”

Read More

Pfizer, BioNTech Plan Clinical Trial for COVID-19 mRNA Vaccine Candidate

Article | February 18, 2020

Pfizer and BioNTech plan to begin human clinical trials on their lead COVID-19 therapeutic candidate, an mRNA vaccine, by the end of this month, the companies said today, through a collaboration that could generate up to $748 million for the German biotech. The companies announced plans last month to partner on BNT162, the first treatment to emerge from BioNTech’s accelerated COVID-19-focused development program, “Project Lightspeed.” BioNTech and Pfizer established collaboration intended to draw upon BioNTech’s proprietary mRNA vaccine platforms, and Pfizer’s expertise in vaccine research and development, regulatory capabilities, and global manufacturing and distribution network.

Read More

5 Biotech Stocks Winning the Coronavirus Race

Article | February 18, 2020

There are quite a few companies that have found ways to grow their business during the ongoing COVID-19 pandemic. This is especially true for a number of biotechs now working on developing a potential treatment for, or vaccine against, the virus; shares of such companies have largely surged over the past couple of months. Although many of these treatments and vaccines are still have quite a way to go before they're widely available, it's still worth taking some time to look through what's going on in the COVID-19 space right now. Here are five biotech stocks that are leading the way when it comes to addressing COVID-19. Regeneron Pharmaceuticals (NASDAQ:REGN) wasn't among the initial wave of companies to announce a potential COVID-19 drug. However, investor excitement quickly sent shares surging when the company announced that its rheumatoid arthritis drug, Kevzara, could help treat COVID-19 patients.

Read More

2 Small-Cap Biotech Stocks You Haven't Heard of, But Should Know About

Article | February 18, 2020

With everything that's going on with the COVID-19 pandemic, many healthcare companies have grabbed plenty of spotlight during these challenging times. At the same time, a number of otherwise promising businesses have slipped under the radar. That's especially true for small-cap biotech stocks that aren't actively involved in developing tests, vaccines or treatments for COVID-19. Vaccine developers, protective equipment producers, and healthcare service providers are all attracting plenty of attention during this pandemic, but there are just as many promising biotech stocks that aren't involved in these areas. Here are two such companies that you might have missed, but they deserve a spot on your watch list.

Read More

Spotlight

Donald Danforth Plant Science Center

The Donald Danforth Plant Science Center is a not-for-profit research institute with a mission to improve the human condition through plant science. Scientists at the Danforth Center are engaged in research, which will contribute to feeding the hungry, improving human health, preserving and renewing the environment, and enhancing the St. Louis region and the State of Missouri as world centers for plant science.

Events